Description
Antibody Name: | Purified Human CD274/PD-L1 Monoclonal Antibody |
Antibody Code: | AGEL1646 |
Size: | 100µg |
Clone: | 29E.2A3 |
Synonyms: | B7-H1, PD-L1,Programmed cell death ligand 1,B7 homolog 1,B7-H, B7H1, PDL1, PDCD1L1, PDCD1LG1 |
Host Species: | Mouse |
Species Reactivity: | Human |
Applications: | FC, IHC |
Concentration: | 1mg/mL |
Isotype: | IgG2a,k |
Conjugation: | Unconjugated |
Applications: | FC, IHC |
Recommended Dilution: | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 10e6 cells in 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. |
Storage Buffer: | PBS with 0.05% Proclin300 |
Storage: | Store at 2-8°C. Do not freeze. |
Gene ID: | 29126 |
Uniprot: | Q9NZQ7 |
Background: | CD274, also known as PD-L1 and B7-H1, is type I transmembrane glycoprotein that serves as a ligand for CD279 (PD-1). This interaction is believed to regulate the balance between the stimulatory and inhibitory signals needed for responses to microbes and maintenance of self-tolerance. CD274 is involved in the costimulation of T cell proliferation and IL-10 and IFN-γ production in an IL-2-dependent and CD279-independent manner. Conflicting data has shown that CD274 can inhibit T cell proliferation and cytokine production, and alternatively, enhance T cell activation. Other studies suggest that CD274 may signal bidirectionally, raising interesting implications for its expression in a wide variety of cell types, including T and B cells, antigen-presenting cells, and nonhematopoietic cells. |